A pde10a inhibitor cpl500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects

HIGHLIGHTS

  • who: . et al. from the University of Catania, Italy have published the research work: A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects, in the Journal: (JOURNAL)
  • what: The authors aimed to evaluate the selectivity against common and pharmacologically relevant off-targets, cytotoxicity, genotoxicity, pharmacokinetics and potential adverse effects of CPL500036 (including catalepsy, metabolic syndrome, hyperprolactinemia, and cardiotoxicity).
  • how: The study was carried out in 40 male Wistar Han rats (~10 weeks Tri-City Academic Laboratory Animal Centre Research and Services Centre Medical University of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?